Clinical Trial Update: Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating intensive locoregional chemoimmunotherapy with intranodal dendritic cell vaccines for recurrent ovarian cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Intranodal dendritic cell vaccine

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Cancer of Ovary, Cancer of the Ovary | Phase 1, Phase 2 | Status: TERMINATED